One and One from Last Week’s Recap
Recap - Merry Christmas and Happy Holidays! Wishing you and yours a spectacular 2015! We were one and one in last week’s healthcare recap. The v-bottom played out as many expected, … Continue Reading
Read NowRecap
V-Bottom’s Back, Gilead’s Biggest Overhang is Removed: Our Weekly Recap
Recap - We’re in the throes of yet another sharp “V-bottom” for the S&P 500 (SPX), a rapid drop followed by a rip-your-face off rally – the 10th occurrence … Continue Reading
Read NowWhat. A. Week. Recapping our Top Stories & Trades
Recap - In biotech investing, rarely do five trading sessions go by without some explosive volatility. This week, it was Merck’s (MRK) acquistion of Cubist Pharmaceuticals (CBST) for $9 billion, and bluebird … Continue Reading
Read Now
One of the Bigger Medical Conferences is Upon Us
Recap - The American Society of Hematology’s annual meeting begins this weekend in San Francisco. It’s a big event for the oncology research community, particularly those studying blood cancers, … Continue Reading
Read NowHoliday Weeks Always Make for Weird Markets
Recap - A happy (belated) Thanksgiving to you and yours! Last week we wrote briefly about the current state of the markets, from a technical perspective. Conclusion: a short-term pull-back … Continue Reading
Read NowOne Simple Chart to Note Before Next Week
Recap - The markets have rebounded precipitously from lows this October, with both the S&P 500 and iShares NASDAQ Biotechnology Index (IBB) making new all-time highs in the … Continue Reading
Read NowOur Weekly Biotech Trading Roundup
Recap - As expected, Trillium Therapeutics (SCTPF)(TR.TO) announced this week an upcoming reverse-split, NASDAQ uplisting, and reiterated the timeline for bringing its SIRPaFc antibody-like fusion proteins into the clinic … Continue Reading
Read Now